Study on lipid-lowering mechanism of active peptide DP17 from Eupolyphaga steleophaga in hyperlipidemia rats.
10.19540/j.cnki.cjcmm.20200709.403
- Author:
Shan JIANG
1
;
Ping-Ping DONG
1
;
L I HAO-RAN
1
;
X U JING
1
;
L I HUA-JIAN
1
;
Y U YING-YING
2
;
Long DAI
3
;
Peng GAO
4
;
Shao-Ping WANG
3
;
Jia-Yu ZHANG
3
Author Information
1. School of Pharmacy, Binzhou Medical University Yantai 264003, China School of Pharmacy,Shandong University of Traditional Chinese Medicine Ji'nan 250355, China.
2. Yantai Affiliated Hospital of Binzhou Medical University Yantai 264000, China.
3. School of Pharmacy, Binzhou Medical University Yantai 264003, China.
4. School of Pharmacy,Shandong University of Traditional Chinese Medicine Ji'nan 250355, China.
- Publication Type:Journal Article
- Keywords:
AMPK;
Eupolyphaga steleophaga;
active peptide;
hyperlipidemia;
mTORC1
- MeSH:
Animals;
Diet, High-Fat/adverse effects*;
Hyperlipidemias/genetics*;
Lipids;
Liver;
Peptides;
Rats;
Triglycerides
- From:
China Journal of Chinese Materia Medica
2020;45(21):5265-5272
- CountryChina
- Language:Chinese
-
Abstract:
The aim of this paper was to investigate the mechanism of the active peptide DP17 of Eupolyphaga steleophaga in the treatment of hyperlipidemia rats. HPLC and MADIL-TOF/TOF-MS were used for the amino acid sequence analysis and solid-phase synthesis on the active peptide of E. steleophaga which were obtained by biomimetic enzymatic hydrolysis, separation and purification. The hyperlipidemia model was established by feeding with high-fat diet.Twenty days later, the rats in the blank group and the model group were given the saline and the rats in remaining groups were given the corresponding drugs by oral administration. After administration for 4 weeks, the levels of triglyceride(TG), total cholesterol(TC) and low density lipoprotein(LDL) in serum, the levels of TG, TC, adenosine monophosphate(AMP), adenosine triphosphate(ATP) in liver tissues and TG in feces were detected, respectively. Hematoxylin-eosin(HE) staining was used to observe the pathological changes of liver tissues. The Real-time fluorescence quantitative PCR method was used to detect the expression of acetyl coa carboxylase(ACC) and hydroxymethylglutaryl-coa reductase(HMGCR) mRNA in liver tissues. The expression of mammalian target of rapamycin(mTORC1) protein and adenosine 5'-monophosphate-activated protein kinase(AMPK) in liver tissues were detected by Western blot. The analysis showed that the amino acid sequence of active peptide from E. steleophaga was DAVPGAGPAGCHPGAGP(DP17). The results of pharmacological experiments showed that after oral administration of DP17 in rats, the levels of TG, TC and LDL in serum as well as TG and TC levels in liver tissues were significantly decreased(P<0.05), while the levels of AMP, ATP in liver tissues and TG content in feces were significantly increased(P<0.05); the liver steatosis of rats was significantly relieved; the expression of ACC, HMGCR mRNA and mTORC1 protein in liver tissues were significantly reduced, while the expression of AMPK phosphorylated protein was significantly increased(P<0.05). DP17, the active peptide of E. steleophag can significantly reduce lipid accumulation in liver tissues, and it may play a role in reducing blood lipids by regulating the energy metabolism balance in the body and activating AMPK/mTOR signaling pathway.
